Michael Taylor
Chairman at Mitokinin, Inc.
Michael Taylor active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cequent Pharmaceuticals, Inc.
 Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Director/Board Member | - | - |
Mission Biocapital (California)
 Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Corporate Officer/Principal | - | - |
Telo Therapeutics, Inc.
 Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Director/Board Member | - | - |
Mitokinin, Inc.
 Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Chairman | - | - |
BioInnovation Management LLC
 BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 31/12/2019 | - |
Career history of Michael Taylor
Former positions of Michael Taylor
| Companies | Position | Start | End |
|---|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Director/Board Member | 28/02/2014 | 22/06/2021 |
| Chief Executive Officer | 28/02/2014 | 17/03/2019 | |
| President | 28/02/2014 | 17/03/2019 | |
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Director/Board Member | 30/06/2007 | 30/09/2013 |
| Chief Executive Officer | 30/06/2007 | 30/09/2013 | |
| President | 30/06/2007 | 30/09/2013 | |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 25/07/2010 | 21/08/2012 |
| Independent Dir/Board Member | 10/05/2011 | 21/08/2012 | |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 31/12/2009 | 31/12/2011 |
| ░░░░░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
Training of Michael Taylor
| State University of New York at Buffalo | Doctorate Degree |
| University of South Florida | Undergraduate Degree |
Statistics
International
| United States | 15 |
Operational
| Director/Board Member | 7 |
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Ensemble Therapeutics Corp.
Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Ensemble Therapeutics Corp. develops novel classes of therapeutics and bioassays for research and diagnostics. The firm focuses on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. The company was founded by Douglas G. Cole, Noubar B. Afeyan and David R. Liu in 2004 and is headquartered in Cambridge, MA. | Process Industries |
Cequent Pharmaceuticals, Inc.
Cequent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cequent Pharmaceuticals, Inc. developed therapeutics and pharmaceuticals. The company was founded in 2006 and was headquartered in Cambridge, MA. | Health Technology |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Health Technology |
BioInnovation Management LLC
BioInnovation Management LLC Investment ManagersFinance BioInnovation Management LLC (Bioinnovation Management) is a venture capital firm founded in 2009 by Peter D Parker and Susie T Harborth. The firm is headquartered in Cambridge, Massachusetts. | Finance |
| Warner-Lambert Co. LLC | |
Mitokinin, Inc.
Mitokinin, Inc. BiotechnologyHealth Technology Mitokinin, Inc. develops kinase neo-substrates for the treatment of neurodegenerative and mitochondrial diseases. The company was founded by Kevan Shokat, Nicholas Hertz, and Daniel de Roulet Jr. and is headquartered in New York, NY. | Health Technology |
Telo Therapeutics, Inc.
Telo Therapeutics, Inc. BiotechnologyHealth Technology Telo Therapeutics, Inc. develops precision medicines to reverse cancer cell immortality. | Health Technology |
Mission Biocapital (California)
Mission Biocapital (California) Investment ManagersFinance BioInnovation LLC is a Angel firm, a subsidiary of BioInnovation LLC founded in 2018. BioInnovation LLC is headquartered in Cambridge. | Finance |
- Stock Market
- Insiders
- Michael Taylor
- Experience